The generally perceived consensus on this message board (wrong) is that in all the world the only people who really know and follow Anavex’s unique sigma-1 receptor activating molecules are the people who read and post messages here. Few others know or care or understand.
Entirely wrong. The science insiders at every Big Pharma closely follow everything that we post here. After all, if the Anavex sigma-1 activation mechanism proves successful, “amyloid focused careers” are truly in danger. Millions upon millions of pharmaceutical drug development dollars are at risk. Entire careers and programs and laboratories are in jeopardy. Would these people decline to examine the Anavex science reports that both the company and we posters display here? Of course not. They keep up to date on everything Anavex posts. They even read and consider the science postings we put up on this message board.
Of course, the general investment communities, both retail equity buyers, and institutional investment firms are, presently, ignorant of Anavex science. Few of them are reading or comprehending what appears on this message board. But after 1 December, readership on this board will explode. Will be fun to watch....